Not exactly. Colorectal cancer is one of 17 different types of cancer rising for Gen X and Millennials, according to American ...

Breast cancer treatments, while life-saving, can impact a woman's fertility. Chemotherapy and radiation therapy, in particular, can damage ovarian function, leading to difficulties conceiving.

Jenna Fischer, 50, said in an Instagram post sharing her breast cancer journey: "My tumor was so small it could not be felt on a physical exam. If I had waited six months longer, things could have ...

Shannon Strohl knew something was amiss. The Manheim Township woman suspected breast cancer when she felt a lump, but her primary care physician wasn’t quite sure. Strohl was only 29 and breast ...

Ahead of the Bengals-Giants game on Sunday, Oct. 13, Jill joined the program to discuss her history with breast cancer and urge viewers to consider genetic testing if they're high risk — a step ...

A woman is "deeply grateful" to artificial intelligence for finding her breast cancer after she was given the all clear following a routine scan. Sheila Tooth from Littlehampton, West Sussex ...

More than $500,000 was expected to be raised for the American Cancer Society. The walk is a celebration of courage and hope and a movement that unites communities to end breast cancer, according ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and where cancer metastasizes. A new randomized controlled trial out of ...

In February, AstraZeneca and Daiichi Sankyo teased the results of their pivotal trial of Enhertu in HER2-low breast cancer, and, at ASCO, they finally revealed the data – with the numbers every ...

Breast cancer has been a formidable health challenge across generations, impacting 2.3 million women globally in 2022 alone. However, decades of dedicated research have gradually transformed this ...

In Europe, approximately 531,000 breast cancer patients are diagnosed annually, with around 141,000 deaths, and around half of all cases would fall under the HER2-low classification, split between ...

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the emerging ...